Skip to main content
. 2023 Jan 10;2023(1):CD001955. doi: 10.1002/14651858.CD001955.pub5

1. Number needed to treat for an additional beneficial outcome for return visits or (re)admissions or both for any glucocorticoid compared to placebo .

Baseline rate (%)  NNTB (95% CI)
Mean baseline rate
30.62 7 (5 to 12)
Smallest baseline rate
2.06 102 (78 to 179)
Largest baseline rate
72.00 3 (2 to 5)

NNTB: number needed to treat for an additional beneficial outcome